Surgical Science Sweden AB (publ)
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator … Read more
Market Cap & Net Worth: Surgical Science Sweden AB (publ) (SUSRF)
Surgical Science Sweden AB (publ) (PINK:SUSRF) has a market capitalization of $587.82 Million ($587.82 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #10925 globally and #4957 in its home market, demonstrating a -12.13% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Surgical Science Sweden AB (publ)'s stock price $11.52 by its total outstanding shares 51026236 (51.03 Million).
Surgical Science Sweden AB (publ) Market Cap History: 2021 to 2025
Surgical Science Sweden AB (publ)'s market capitalization history from 2021 to 2025. Data shows change from $1.63 Billion to $587.82 Million (-4.59% CAGR).
Surgical Science Sweden AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Surgical Science Sweden AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.74x
Surgical Science Sweden AB (publ)'s market cap is 0.74 times its annual revenue
1.52x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
4.94x
Surgical Science Sweden AB (publ)'s market cap is 4.94 times its annual earnings
245.34x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.63 Billion | $366.78 Million | $86.25 Million | 4.45x | 18.93x |
| 2022 | $824.07 Million | $802.54 Million | $187.97 Million | 1.03x | 4.38x |
| 2023 | $604.15 Million | $882.85 Million | $233.97 Million | 0.68x | 2.58x |
| 2024 | $650.58 Million | $884.09 Million | $131.65 Million | 0.74x | 4.94x |
Competitor Companies of SUSRF by Market Capitalization
Companies near Surgical Science Sweden AB (publ) in the global market cap rankings as of March 19, 2026.
Key companies related to Surgical Science Sweden AB (publ) by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #731 globally with a market cap of $27.76 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #942 globally with a market cap of $20.52 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2200 globally with a market cap of $6.92 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2264 globally with a market cap of $6.67 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #731 | Veeva Systems Inc Class A | NYSE:VEEV | $27.76 Billion | $184.03 |
| #942 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $20.52 Billion | $144.35 |
| #2200 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.92 Billion | $43.07 |
| #2264 | HealthEquity Inc | NASDAQ:HQY | $6.67 Billion | $79.57 |
Surgical Science Sweden AB (publ) Historical Marketcap From 2021 to 2025
Between 2021 and today, Surgical Science Sweden AB (publ)'s market cap moved from $1.63 Billion to $ 587.82 Million, with a yearly change of -4.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $587.82 Million | -9.65% |
| 2024 | $650.58 Million | +7.69% |
| 2023 | $604.15 Million | -26.69% |
| 2022 | $824.07 Million | -49.53% |
| 2021 | $1.63 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Surgical Science Sweden AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $587.82 Million USD |
| MoneyControl | $587.82 Million USD |
| MarketWatch | $587.82 Million USD |
| marketcap.company | $587.82 Million USD |
| Reuters | $587.82 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.